Stay updated on Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page

  1. Check
    14 days ago
    No Change Detected
  2. Check
    20 days ago
    Change Detected
    Summary
    The study record now includes links to the Study Protocol and Statistical Analysis Plan, adds an IPD sharing plan, and notes that the trial operates at 51 locations.
    Difference
    81%
    Check dated 2026-08-15T23:17:23.000Z thumbnail image
  3. Check
    28 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous v3.6.4. This reflects an updated revision stamp for the page.
    Difference
    0.0%
    Check dated 2026-08-08T17:48:17.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page. This represents an administrative update to the study record rather than changes to trial content.
    Difference
    0.0%
    Check dated 2026-07-25T08:22:34.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    The page displays Revision: v3.6.3, replacing the previous v3.6.2. This update signals a new page version but does not change the study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-07-03T21:44:23.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer software/content update. This change does not modify the study information or its presentation to users.
    Difference
    0.0%
    Check dated 2026-06-26T23:55:40.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added explicit notice that no participants are being recruited anymore, clarifying the study's enrollment status. The page also introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment labeling and revision marker to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:48:35.000Z thumbnail image

Stay in the know with updates to Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.